emavusertib

'The decision is clear': Curis cuts workforce as pending data hint at near-term FDA application
Fierce Biotech
Thu, 11/10/22 - 10:39 pm
Curis
layoffs
emavusertib
FDA partially clears Curis leukemia trial in second August regulatory win
Pharma Live
Tue, 08/30/22 - 06:03 pm
Curis
FDA
emavusertib
clinical trials
FDA lifts partial hold on Curis' lymphoma study — shares spike
Endpoints
Thu, 08/18/22 - 11:08 am
FDA
Curis
lymphoma
clinical trials
emavusertib
FDA Sends Curis Cancer Drug into Holding Pattern
BioSpace
Tue, 04/12/22 - 11:01 am
Curis
FDA
emavusertib
clinical trials
FDA puts Curis' leukemia trial on partial hold after patient death spurs review of muscle breakdown
Fierce Biotech
Mon, 04/4/22 - 10:35 am
Curis
FDA
clinical trials
patient deaths
emavusertib
acute myeloid leukemia